Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Fierce Biotech
FDA's 'heavy workload' blamed for delaying KalVista's PDUFA date
KalVista has become the latest biotech to face delays to FDA decision-making, as the agency blames a “heavy workload” for pushing back a PDUFA date.
James Waldron
Jun 16, 2025 4:33am
Fierce Biotech
FDA hopes AI can deliver 'rapid or instant' reviews
Jun 11, 2025 12:45pm
Fierce Biotech
FDA refuses Axsome filing for former Pfizer fibromyalgia asset
Jun 9, 2025 12:27pm
Fierce Biotech
At cell and gene roundtable, officials pledge to slash regulations
Jun 5, 2025 2:50pm
Lack of global regulatory alignment spurs bad actors, FDA says
May 9, 2024 10:15am
Pharma heads for cancer first line, causing early-stage rethink
Nov 17, 2023 3:00am